Published in Joint Bone Spine on September 01, 2004
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50
Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) (2000) 22.00
Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol (1993) 18.09
Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG) Am J Ind Med (1996) 16.45
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum (1995) 15.00
Mortality among patients admitted to hospitals on weekends as compared with weekdays. N Engl J Med (2001) 10.69
Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med (1991) 10.55
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
Outcome measures for low back pain research. A proposal for standardized use. Spine (Phila Pa 1976) (1998) 6.51
Differences between men and women in the rate of use of hip and knee arthroplasty. N Engl J Med (2000) 6.29
Measuring disease-specific quality of life in clinical trials. CMAJ (1986) 5.56
Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther (2001) 5.10
Shopping around for hospital services: a comparison of the United States and Canada. JAMA (1998) 4.41
Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol (1993) 4.39
Determining the need for hip and knee arthroplasty: the role of clinical severity and patients' preferences. Med Care (2001) 4.27
Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ (2001) 4.06
Waiting times for knee-replacement surgery in the United States and Ontario. N Engl J Med (1994) 3.96
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95
Health-related quality of life after knee replacement. J Bone Joint Surg Am (1998) 3.88
Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res (1996) 3.40
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1994) 3.24
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
A taxonomy for responsiveness. J Clin Epidemiol (2001) 3.03
Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol (1997) 2.92
What do we know about the reliability and validity of physical examination tests used to examine the upper extremity? J Hand Surg Am (1999) 2.65
Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain. Cochrane Database Syst Rev (2002) 2.65
Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int (2004) 2.62
Primer on medical decision analysis: Part 1--Getting started. Med Decis Making (1997) 2.61
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis (2004) 2.60
Determinants of physician confidence in the primary care management of musculoskeletal disorders. J Rheumatol (1996) 2.55
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun (2005) 2.47
Management of common musculoskeletal problems: a survey of Ontario primary care physicians. CMAJ (1998) 2.41
Long-term follow-up of survivors of acute lung injury: lack of effect of a ventilation strategy to prevent barotrauma. Crit Care Med (1999) 2.29
"Are you better?" A qualitative study of the meaning of recovery. Arthritis Rheum (2001) 2.24
Comparison of a generic (SF-36) and a disease specific (WOMAC) (Western Ontario and McMaster Universities Osteoarthritis Index) instrument in the measurement of outcomes after knee replacement surgery. J Rheumatol (1995) 2.23
Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol (1993) 2.14
Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol (1983) 2.13
Preventing disability from work-related low-back pain. New evidence gives new hope--if we can just get all the players onside. CMAJ (1998) 2.12
Models of disablement, universalism and the international classification of impairments, disabilities and handicaps. Soc Sci Med (1999) 2.11
Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Am J Med (1986) 2.08
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med (1997) 2.04
Socioeconomic factors affecting the utilization of surgical operations. N Engl J Med (1977) 2.02
A systematic review of the prognosis of acute whiplash and a new conceptual framework to synthesize the literature. Spine (Phila Pa 1976) (2001) 1.99
The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis (2004) 1.92
The consultant's role in continuing medical education of general practitioners: the case of rheumatology. Br Med J (Clin Res Ed) (1987) 1.85
Primer on medical decision analysis: Part 3--Estimating probabilities and utilities. Med Decis Making (1997) 1.84
Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome. Am J Respir Crit Care Med (2000) 1.81
Ontario patients' acceptance of waiting times for knee replacements. J Rheumatol (1994) 1.80
Determinants of self rated health for Canadians with chronic disease and disability. J Epidemiol Community Health (1999) 1.80
Biomechanical and psychosocial risk factors for low back pain at work. Am J Public Health (2001) 1.78
Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int (2011) 1.77
Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ (2000) 1.71
Management of the early and late presentations of rheumatoid arthritis: a survey of Ontario primary care physicians. CMAJ (1996) 1.70
Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev (2002) 1.69
The prevalence and severity of major disabling conditions--a reappraisal of the government social survey on the handicapped and impaired in Great Britain. Int J Epidemiol (1978) 1.68
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches. J Rheumatol (1983) 1.66
Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol (2001) 1.64
Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology (Oxford) (2000) 1.64
Discharge after discharge: predicting surgical site infections after patients leave hospital. J Hosp Infect (2010) 1.63
Osteoarthritis of the hip and knee and mechanical occupational exposure--a systematic overview of the evidence. J Rheumatol (1997) 1.62
Continuous electrocardiographic monitoring and cardiac arrest outcomes in 8,932 telemetry ward patients. Acad Emerg Med (2000) 1.60
Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum (1999) 1.59
Primer on medical decision analysis: Part 2--Building a tree. Med Decis Making (1997) 1.58
Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results. Med Decis Making (1997) 1.57
Systematic reviews of low back pain prognosis had variable methods and results: guidance for future prognosis reviews. J Clin Epidemiol (2009) 1.57
Classification systems of soft tissue disorders of the neck and upper limb: do they satisfy methodological guidelines? J Clin Epidemiol (1996) 1.56
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet (1990) 1.56
Setting the agenda for multiple sclerosis rehabilitation research. Mult Scler (2008) 1.55
Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum (1989) 1.55
A randomized controlled trial to assess the incidence of new onset hypertension in patients after shock wave lithotripsy for asymptomatic renal calculi. J Urol (1998) 1.54
In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide. Eur J Endocrinol (1995) 1.53
Problems for clinical judgement: 4. Surviving in the report card era. CMAJ (2001) 1.52
Variation in orthopedic surgeons' perceptions of the indications for and outcomes of knee replacement. CMAJ (1995) 1.51
Emergency department overcrowding following systematic hospital restructuring: trends at twenty hospitals over ten years. Acad Emerg Med (2001) 1.48
Risk of premature stroke in recent immigrants (PRESARIO): population-based matched cohort study. Neurology (2010) 1.44
Measuring injury severity: time for a change? J Trauma (1998) 1.40
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. Arthritis Care Res (Hoboken) (2012) 1.40
The nature of increased hospital use in poor neighbourhoods: findings from a Canadian inner city. Can J Public Health (2000) 1.40
The provision of specialist rheumatology care: implications from a survey of rheumatologists in Ontario, Canada. J Rheumatol (1995) 1.40
Heterotopic ossification after primary cemented and noncemented total hip arthroplasty in patients with osteoarthritis and rheumatoid arthritis. Can J Surg (1994) 1.40
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med (1990) 1.40
The effectiveness of a regulatory strategy in containing hospital costs. The Ontario experience, 1967-1981. N Engl J Med (1983) 1.39
Primer on medical decision analysis: Part 5--Working with Markov processes. Med Decis Making (1997) 1.39
Physical disability among Canadians reporting musculoskeletal diseases. J Rheumatol (1992) 1.39
Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum (1999) 1.38
Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol (2000) 1.37
Investigating non-response bias in a survey of disablement in the community: implications for survey methodology. J Epidemiol Community Health (1991) 1.37
Adaptation to chronic illness and disability and its relationship to perceptions of independence and dependence. J Gerontol B Psychol Sci Soc Sci (2000) 1.37
Measuring disability of the upper extremity: a rationale supporting the use of a regional outcome measure. J Hand Ther (2000) 1.36
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol (1994) 1.35
The normal human esophageal mucosa: a histological reappraisal. Gastroenterology (1975) 1.35
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol (1992) 1.34
Accuracy of administrative data for assessing outcomes after knee replacement surgery. J Clin Epidemiol (1997) 1.34
Validity of rheumatoid arthritis diagnoses listed in the Saskatchewan Hospital Separations Database. J Clin Epidemiol (1993) 1.34